密歇根州医院心脏骤停后结局存在显著差异
该研究利用密歇根CARES registry,纳入2014-2017年成人院外心脏骤停(OHCA)且ROSC后存活入院的患者,分析39家收治>30例的医院。共4690例纳入分析,出院生存率中位数31.3%(范围12.5%-46.7%),出院时CPC 1-2生存率中位数25.0%(范围5.2%-42.2%)。多因素校正后,中位校正出院生存率为26.9%(范围18.1%-42.1%),CPC 1-2生存率为21.3%(范围9.6%-32.1%)。医院间TTM使用率差异达12倍(中位47.9%,范围6.7%-80.0%),LHC使用率差异近8倍(中位22.1%,范围5.4%-42.2%)。
要点
- 39家医院出院生存率中位数31.3%,范围12.5%-46.7%,医院间差异达4倍。
- 出院时CPC 1-2生存率中位数25.0%,范围5.2%-42.2%,医院间差异达8倍。
- TTM使用率医院间差异达12倍(中位47.9%,范围6.7%-80.0%)。
- LHC使用率医院间差异近8倍(中位22.1%,范围5.4%-42.2%)。
- 多因素校正后生存差异仍存在(校正后中位26.9%,范围18.1%-42.1%),提示部分医院可通过质量改进提升结局。
适用人群与场景
- 成人院外心脏骤停(OHCA)患者,ROSC后存活至入院,来自密歇根CARES registry 2014-2017年数据。
- 纳入39家密歇根医院,研究期间收治>30例OHCA病例的医院。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:基于州级registry的多中心回顾性队列研究,39家医院,纳入4690例成人OHCA后ROSC存活入院患者。
- 主要终点:出院生存率中位数31.3%(范围12.5%-46.7%);出院时CPC 1-2生存率中位数25.0%(范围5.2%-42.2%)。
- 多因素校正后:中位校正出院生存率26.9%(范围18.1%-42.1%);中位校正CPC 1-2生存率21.3%(范围9.6%-32.1%)。
- TTM使用率中位47.9%(范围6.7%-80.0%),医院间差异12倍;LHC使用率中位22.1%(范围5.4%-42.2%),差异近8倍。
- 医院间生存差异在校正后减弱但仍持续存在,未被现有协变量完全解释。
证据类型、等级与局限
- 证据类型:基于密歇根CARES registry的多中心回顾性队列研究。
- 局限:观察性设计,无法排除未测量混杂;仅纳入密歇根州39家医院,外推性受限;原文未提及证据等级或推荐强度。
对床旁实践的改变
- 提示OHCA复苏后存活入院患者的出院生存率及神经功能结局在医院间存在显著差异,部分医院可能通过质量改进活动提升结局。
- TTM和LHC使用率在医院间差异显著(分别为12倍和8倍),提示存在实践异质性,但原文未给出具体操作推荐。
- 原文未提及适用与不适用人群的具体标准。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM: Resuscitation from out of hospital cardiac arrest (OHCA) requires success across the entire chain of survival. Using a large state-wide registry, we characterized variation in clinical outcomes at hospital discharge in Michigan hospitals.
METHODS: We utilized the Michigan Cardiac Arrest Registry to Enhance Survival (CARES) and included adult OHCA subjects with return of spontaneous circulation (ROSC) from 2014 - 2017 that survived to hospital admission. 39 Michigan hospitals were included which managed >30 cases during the study period. Multilevel logistic regression, controlling for both subject characteristics and clustering of subjects within hospitals, assessed variation across hospitals in survival to hospital discharge and survival with cerebral performance category (CPC 1-2).
RESULTS: There were 5,486 CARES subjects that survived to hospital admission, and 4,690 met inclusion for analysis. Of 39 included hospitals, median survival to discharge was 31.3% (range 12.5%-46.7%) and median survival to discharge with CPC 1-2 was 25.0% (range 5.2%-42.2%). We identified 12-fold variation in the utilization of TTM by hospital (median 47.9%, range 6.7%-80.0%) for all admitted subjects. Similarly, there was nearly an eight-fold variation in LHC for all post-arrest subjects (median 22.1%, range 5.4%-42.2%). In multivariable analyses, median adjusted survival to discharge was 26.9% (range 18.1%-42.1%) and median adjusted survival to discharge with CPC 1-2 was 21.3% (range 9.6%-32.1%).
CONCLUSION: We observed substantial variation in clinical outcomes at discharge between Michigan hospitals, including a four-fold range of survival and eight-fold range of survival with CPC 1-2. This variation was ameliorated but still persisted in adjusted modeling. Variation in post arrest survival by hospital was not fully explained by available covariates, which suggests the possibility of improving post-arrest clinical outcomes at some hospitals via quality improvement activities.
参考来源
- Berger DA, Chen NW, Miller JB, et al. Substantial variation exists in post-cardiac arrest outcomes across Michigan hospitals. Resuscitation. 2020. PMID: 33221364. doi:10.1016/j.resuscitation.2020.11.007
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。